1-4 of 4
Anita Boyapati, Ph.D.
Close
Sort by
Journal Articles

Disruption of the NHR4 Domain Structure in AML1-ETO Abrogates Its Interaction with SON and Promotes AML1-ETO-Associated Leukemogenesis.

Eun-Young Ahn, PhD, Ming Yan, Ph.D., Oxana A Malakhova, M.S., Anita Boyapati, Ph.D., Hans Beier Ommen, M.D., Robert Hines, Ph.D., Peter Hokland, M.D., Dong-Er Zhang, Ph.D.
Journal: Blood
Blood (2008) 112 (11): 936.
https://doi.org/10.1182/blood.V112.11.936.936
Published: 2008
Journal Articles

The Dimerization Domain and C-Terminal NCoR/SMRT Interacting Zinc-Finger Domain of t(8;21) Fusion Protein AML1-ETO Have Critical and Opposite Effects on Leukemogenesis.

Ming Yan, Ph.D, Eiki Kanbe, M.D.-Ph.D., Luke F. Peterson, Ph.D., Anita Boyapati, Ph.D., Robert Hines, Ph.D., Dong-Er Zhang, Ph.D.
Journal: Blood
Blood (2004) 104 (11): 2556.
https://doi.org/10.1182/blood.V104.11.2556.2556
Published: 2004
Journal Articles

Identification of a Novel Alternatively Spliced Form of AML1-ETO and Analysis of Its Role in Leukemogenesis.

Eiki Kanbe, M.D.-Ph.D., Yang Wang, M.D.-Ph.D., Anita Boyapati, Ph.D., Ming Yan, Ph.D., Luke F. Peterson, Ph.D., Cheryl L. Willman, M.D., Janet D. Rowley, M.D., Don-Er Zhang, Ph.D.
Journal: Blood
Blood (2004) 104 (11): 545.
https://doi.org/10.1182/blood.V104.11.545.545
Published: 2004
Journal Articles

Differential Effects on Cell Cycle Regulators by AML1-ETO and a C-Terminal Truncated AML1-ETO (From Tumor Suppressor to Oncogene).

Luke F. Peterson, Ph.D., Ming Yan, Ph.D., Anita Boyapati, Ph.D., Dong-Er Zhang, Ph.D.
Journal: Blood
Blood (2004) 104 (11): 2052.
https://doi.org/10.1182/blood.V104.11.2052.2052
Published: 2004